Posted on

FDA Gives Cognito Therapeutics Breakthrough Status on it’s Alzheimer Headset

th 2200758764

the staff of the Ridgewood blog

Ridgewood NJ, Cognito Therapeutics Inc. will soon be conducting late-stage trials of a device for treating Alzheimer’s disease. The trial will involve around 500 US participants wearing a headset for an hour a day over a year. The headset delivers light and sound at a frequency that improves cognitive ability. If Cognito’s headset proves effective, it could see wide adoption in 2024.

The participants will wear a headset for an hour a day for a year. The headset will deliver light and sound at a frequency that, according to prior Cognito studies including one in the journal Neurology, delivers improved cognitive ability among people with Alzheimer’s.

  20% off all web services with Spark Driven https://1.sparkdriven.com/aff.php?aff=3  

One thought on “FDA Gives Cognito Therapeutics Breakthrough Status on it’s Alzheimer Headset

  1. It’s amazing how many people that retired from the village are using legalized marijuana/weed/edibles. So many of them say it helps him each and every day. Very interesting.

Leave a Reply

Your email address will not be published. Required fields are marked *